Ads
related to: regeneron's covid-19- Prescribing Information
Find Prescribing Info & Other
Resources on the HCP Site.
- Register for Updates
Register Here to Get the Latest
Updates for VEKLURY®.
- Prescribing Information
Search results
Regeneron (REGN) Q3 Earnings & Sales Top, Eylea Sales Decline
Zacks via Yahoo Finance· 7 months agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected third-quarter 2023 results, even...
What's in Store for Regeneron Pharmaceuticals (REGN) in 2023?
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals REGN outperformed the biotech industry in 2022 and is all set for a steady...
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive via Yahoo Finance· 1 month agoDive Brief: Regeneron Pharmaceuticals is upping its investment in genetic medicine, announcing Thursday a $100 million deal with CRISPR drug developer...
Why Biden's bout with COVID-19 is likely to be easier than Trump's
LA Times via Yahoo News· 2 years agoPresident Biden walks on the South Lawn of the White House after stepping off Marine One on...
Should You Sell This Stock Following a Regulatory Roadblock?
Motley Fool via Yahoo Finance· 2 months agoBiotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) has been on fire over the past three years....
Covid-19 has changed and so has our immunity. Here’s how to think about risk from the virus now
CNN via Yahoo News· 9 months agoCovid-19 was never just another cold. We knew it was going to stick around and keep changing to try...
Regeneron allays competition fears for 'gold standard' eye drug, shares rise
Reuters via Yahoo News· 2 years ago(Reuters) -Regeneron Pharmaceuticals said on Wednesday it expects demand for blockbuster eye drug...
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
Benzinga via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals Inc (NASDAQ: REGN) earned adjusted EPS of $10.09, down 12% Y/Y, beating...
Regeneron Pharmaceuticals Inc (REGN) Reports Modest Revenue Growth Amidst Strong Dupixent Sales
GuruFocus.com via Yahoo Finance· 4 months agoRevenue Growth: Full year 2023 revenues increased by 8% to $13.12 billion, with a 14% rise excluding...
Will Loss of REGEN-COV Sales Hurt Regeneron (REGN) in 2022?
Zacks via Yahoo Finance· 2 years agoBiotech giant Regeneron Pharmaceuticals REGN witnessed a massive surge in sales in 2021, driven by...
Ads
related to: regeneron's covid-19